GAM Holding AG Acquires 9,081 Shares of Danaher Corporation $DHR

GAM Holding AG increased its holdings in shares of Danaher Corporation (NYSE:DHR) by 71.0% in the third quarter, Holdings Channel.com reports. The fund owned 21,880 shares of the conglomerate’s stock after buying an additional 9,081 shares during the quarter. GAM Holding AG’s holdings in Danaher were worth $4,338,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Advisors Asset Management Inc. boosted its position in Danaher by 1.1% in the 1st quarter. Advisors Asset Management Inc. now owns 6,493 shares of the conglomerate’s stock valued at $1,331,000 after buying an additional 73 shares during the period. Gotham Asset Management LLC boosted its holdings in shares of Danaher by 29.0% in the first quarter. Gotham Asset Management LLC now owns 73,602 shares of the conglomerate’s stock valued at $15,088,000 after purchasing an additional 16,559 shares during the period. Jacobs Levy Equity Management Inc. bought a new position in Danaher in the first quarter worth approximately $40,990,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Danaher by 5.1% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 66,750 shares of the conglomerate’s stock worth $13,684,000 after purchasing an additional 3,216 shares during the period. Finally, Napean Trading & Investment Co Singapore PTE Ltd raised its position in Danaher by 16.2% during the 1st quarter. Napean Trading & Investment Co Singapore PTE Ltd now owns 64,498 shares of the conglomerate’s stock valued at $13,222,000 after purchasing an additional 9,001 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Georgeann Couchara sold 5,174 shares of the firm’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $210.42, for a total value of $1,088,713.08. Following the completion of the sale, the senior vice president owned 2,625 shares of the company’s stock, valued at approximately $552,352.50. This trade represents a 66.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Brian W. Ellis sold 21,776 shares of the business’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the sale, the senior vice president owned 14,553 shares in the company, valued at $3,190,454.19. The trade was a 59.94% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 30,248 shares of company stock worth $6,609,663. 11.10% of the stock is owned by insiders.

Danaher Trading Up 0.7%

NYSE DHR opened at $230.42 on Friday. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23. The company has a 50 day moving average price of $223.80 and a 200 day moving average price of $209.10. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. The firm has a market cap of $162.76 billion, a PE ratio of 47.51, a price-to-earnings-growth ratio of 4.07 and a beta of 0.89.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.17. The business had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.71 earnings per share. As a group, sell-side analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Friday, December 26th. Danaher’s dividend payout ratio is currently 26.39%.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on DHR shares. HSBC raised their price target on Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research note on Monday, December 1st. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research report on Monday. Jefferies Financial Group upped their price target on shares of Danaher from $245.00 to $255.00 and gave the stock a “buy” rating in a research report on Wednesday, December 17th. The Goldman Sachs Group began coverage on shares of Danaher in a report on Tuesday, December 9th. They set a “buy” rating and a $265.00 price objective on the stock. Finally, Redburn Partners set a $220.00 price objective on shares of Danaher in a research note on Wednesday, October 8th. Twenty-one research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $248.25.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.